Company Filing History:
Years Active: 1981
Title: The Innovations of Derek C Ellwood
Introduction
Derek C Ellwood is a notable inventor based in Salisbury, GB. He has made significant contributions to the field of immunology through his innovative research and patent work. His expertise lies in the development of immunogenic cell envelope preparations, which have important implications for vaccine development.
Latest Patents
Derek C Ellwood holds a patent for "Immunogenic cell envelope preparations." This patent describes a method for isolating an antigenically-active cell envelope fraction from bacterial cells, particularly Bordetella pertussis. The process involves disrupting the bacterial cells, separating the cell envelopes from other components, and extracting the envelopes using a zwitterionic surfactant solution. The resulting cell envelope preparation is precipitated using a lower alkyl alcohol, such as ethanol. This innovative approach results in a cell envelope fraction that is highly protective against whole bacteria, as demonstrated by standard vaccine mouse potency assays. Importantly, this preparation has a significantly reduced lipopolysaccharide content, minimizing the risk of undesirable side effects from vaccination.
Career Highlights
Derek C Ellwood is associated with the Secretary of State in Her Britannic Majesty's Government. His work has been instrumental in advancing the understanding of bacterial cell envelopes and their potential use in vaccines. His research has garnered attention for its practical applications in immunology and public health.
Collaborations
Derek has collaborated with notable colleagues, including Richard J Manchee and Andrew Robinson. These partnerships have contributed to the success of his research and the development of his patented innovations.
Conclusion
Derek C Ellwood's contributions to the field of immunology through his patent on immunogenic cell envelope preparations highlight his innovative spirit and dedication to advancing vaccine technology. His work not only enhances our understanding of bacterial immunology but also paves the way for safer and more effective vaccines.